The scavenger receptor CD36 recognizes a diverse set of ligands and has been implicated in a wide variety of normal and pathological processes, including lipid metabolism, angiogenesis, atherosclerosis, and phagocytosis. In particular, recent findings have demonstrated its crucial functions in sterile inflammation and tumor metastasis. However, the role of CD36 in immune-mediated hepatitis remains unclear. Concanavalin A (ConA)-induced liver injury is a well-established experimental T cell-mediated hepatitis. To understand the role of CD36 in hepatitis, we tested the susceptibility of CD36-deficient (CD36 2/2 ) mice to this model, evaluated by a liver enzyme test, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay, histological analysis, mononuclear cell (MNC) infiltration, and hepatic proinflammatory factor production. CD36
The scavenger receptor CD36 recognizes a diverse set of ligands and has been implicated in a wide variety of normal and pathological processes, including lipid metabolism, angiogenesis, atherosclerosis, and phagocytosis. In particular, recent findings have demonstrated its crucial functions in sterile inflammation and tumor metastasis. However, the role of CD36 in immune-mediated hepatitis remains unclear. Concanavalin A (ConA)-induced liver injury is a well-established experimental T cell-mediated hepatitis. To understand the role of CD36 in hepatitis, we tested the susceptibility of CD36-deficient (CD36
2/2
) mice to this model, evaluated by a liver enzyme test, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay, histological analysis, mononuclear cell (MNC) infiltration, and hepatic proinflammatory factor production. CD36
2/2 mice were less sensitive to ConA-induced hepatitis and had a significantly lower number of liver MNCs (LMNCs), including CD4 1 cells, CD8 1 T cells, natural killer cells, natural killer T cells, infiltrating macrophages, and neutrophils, as well as reduced expression of inflammatory mediators (tumor necrosis factor a, CXC chemokine ligand (CXCL) 10, interleukin (IL)-1a, monocyte chemotactic protein 1, and IL-6) compared with controls. Notably, we used bone marrow chimeric mice to demonstrate that CD36 expression on nonhematopoietic cells was required to drive ConA-induced liver injury. Furthermore, our data show that the CD36 receptor was essential for CXCL10-induced hepatocyte apoptosis and activation of IjB kinase, Akt, and Jun N-terminal kinase. Moreover, treatment of wild-type mice with genistein, a tyrosine kinase inhibitor that blocks CD36-Lyn signaling, attenuated ConA-induced liver injury and reduced the number of MNCs. Conclusions: Our findings suggest that CD36 plays an important proinflammatory role in ConA-induced liver injury by promoting hepatic inflammation and mediating the proapoptotic effect of chemokine CXCL10, and therefore, may be a potential therapeutic target for immune-mediated hepatitis. (HEPATOLOGY 2018; 67:1943 -1955 ).
T he liver is a frontline immunological organ containing numerous innate and adaptive immune cells that participate in coordinated immune responses leading to pathogen clearance, leukocyte recruitment, and antigen presentation. (1) Immune-mediated hepatitis occurs when the body's immune system attacks hepatocytes or cholangiocytes in autoimmune disease and when virus-specific T cells destroy infected hepatocytes in viral hepatitis. It is driven by sustained inflammation and damage associated with continuing recruitment, retention, and survival of effector leukocytes within the inflamed livers. (2) The underlying pathophysiological mechanisms are still unclear and therefore, therapeutic options remain a challenge.
CD36 is an integral membrane glycoprotein expressed on the surface of a wide variety of cells such as platelets, monocytes/macrophages, and endothelial and smooth Abbreviations: ALT, alanine aminotransferase; AST, aspartate transaminase; CXCL, CXC chemokine ligand; ConA, concanavalin A; ERK, extracellular regulated protein kinase; FMO, fluorescence minus one; H&E, hematoxylin and eosin; IFN-c, interferon c; IKK, IjB kinase; IgG, immunoglobulin G; IL, interleukin; IM, infiltrating macrophage; JNK, Jun N-terminal kinase; LMNC, liver mononuclear cell; MCP-1, monocyte chemotactic protein 1; MNC, mononuclear cell; mRNA, messenger RNA; NF-jB, nuclear factor kappa B; NK, natural killer; NKT, natural killer T; PBS, phosphate-buffered saline; SEM, standard error of the mean; STAT3, signal transducer and activator of transcription 3; TLR, Toll-like receptor; TNF-a, tumor necrosis factor a; TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labeling; WT, wild-type. muscle cells. It serves as a scavenger receptor for oxidized phospholipids, thrombospondins, fibrillar b-amyloid, apoptotic cells, malaria-infected erythrocytes, and certain microbial pathogens. (3) As a pattern recognition receptor, CD36 has been implicated in a wide variety of normal and pathological processes, including immunity, fatty acid metabolism, angiogenesis, atherosclerosis, and phagocytosis. (3) Recently, it was reported that CD36 ligands promote sterile inflammation through the assembly of a Toll-like receptor 4 and 6 heterodimer. (4) Moreover, CD36 was positioned as a central regulator of sterile inflammation by coordinating NLRP3 inflammasome activation. (5) Notably, CD36 was demonstrated to be coexpressed with integrin alpha 6 and CD133 in cancer stem cells to drive glioblastoma progression. (6) Inhibition of the CD36 receptor impairs tumor metastasis in human melanoma, oral, and breast cancers. (7) Although the role of CD36 in cardiovascular disease, adipose tissue inflammation, and macrophage migration has been studied comprehensively, how and to what extent CD36 contributes to immune-mediated hepatic injury has not been investigated.
Concanavalin A (ConA)-induced liver injury is a well-established murine model of T cell-mediated hepatitis. Intravenous injection of ConA induces acute liver injury and systemic immune activation in mice, which resembles the pathology of immune-mediated hepatitis in humans. (8) In this model, CD4 1 T cells,
CD8
1 T cells, natural killer (NK), natural killer T (NKT) cells, and macrophages induce hepatocyte cell death through cell-to-cell contact; secretion of proinflammatory cytokines such as tumor necrosis factor a (TNF-a), interferon c (IFN-c), interleukin (IL)-2, IL-6, and granulocyte macrophage colony-stimulating factor; or reactive oxygen species. (9) In this study, we investigated the proapoptotic role of CD36 in ConA-induced hepatitis. We demonstrated that the absence of CD36 greatly ameliorated liver injury upon ConA challenge, accompanied by reduced liver mononuclear cells (LMNCs) and decreased proinflammatory factor levels. We also found that the CD36 receptor is essential for the proapoptotic effects of CXC chemokine ligand (CXCL) 10. Furthermore, the protein tyrosine kinase inhibitor genistein, which blocks CD36-TLR4-TLR6 signaling, (4) was able to attenuate ConA-induced liver damage. Thus, our data demonstrate that CD36 plays an important role in ConAinduced liver injury and therefore may be a potential therapeutic target in immune-mediated hepatitis.
Methods and Materials

ANIMALS
C57BL/6J wild-type (WT) and CD36 2/2 mice were housed under specific pathogen-free conditions. Experiments were performed with male animals at 8-10 weeks of age under ethical conditions approved by the Laboratory Animal Core Facility of Nanjing Medical University.
ConA-INDUCED HEPATITIS
A single dose of ConA (Sigma-Aldrich, St. Louis, MO) was injected at 12 or 15 mg/kg through the tail vein to induce acute hepatitis in mice. Genistein (AMQUAR, Shanghai, China) was injected intraperitoneally at 10 mg/kg immediately after ConA treatment. CXCL10 neutralizing antibodies (clone 134013, #MAB466, R&D Systems, Minneapolis, MN) or control antibodies (rat IgG, Bioss Antibodies, Beijing, China) were intravenously injected concomitantly to ConA into the mice (20 lg/mouse).
BIOCHEMICAL AND HISTOLOGICAL ANALYSES
Blood was collected 8 hours after ConA injection and serum alanine aminotransferase (ALT) measurement. For histological analysis, the isolated livers were fixed in 10% formalin, embedded in paraffin, sectioned (4 lm), and stained with hematoxylin and eosin (H&E) for light microscopic evaluation.
ISOLATION OF HEPATOCYTES AND LMNCs
LMNCs from mice were isolated following a previously established method. (10, 11) The isolation and culture of primary hepatocytes were performed as described previously. (12) 
FLOW CYTOMETRY
Freshly isolated hepatic mononuclear cells (MNCs) were incubated with anti-mouse CD16/32 antibody (clone 93, eBioscience, San Diego, CA) for 10 minutes to prevent nonspecific binding before staining with various antibodies. For TNF-a, IFN-c, and CXCL10 intracellular staining, a Foxp3/transcription factor staining buffer set (#00-5523-00, eBioscience) was used according to the manufacturer's manual.
WESTERN BLOTTING
Western blotting was performed as described previously. (11) TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-MEDIATED dUTP NICK END LABELING ASSAY Apoptotic cells were evaluated using the TUNEL assay kit (Roche Applied Science, Penzberg, Germany) according to the manufacturer's instructions.
MEASUREMENT OF CYTOKINE LEVELS IN THE SERUM
Serum levels of IL-6 and monocyte chemotactic protein 1 (MCP-1) were measured using an enzymelinked immunosorbent assay kit (Biolegend, San Diego, CA) according to the manufacturer's protocol.
STATISTICAL ANALYSIS
Data were analyzed using Graphpad Prism (version 6.0). All values are expressed as the mean 6 standard error of the mean. Differences between groups were assessed by means of a two-tailed unpaired Student t test or analysis of variance for comparison of two or multiple groups, respectively. Additional details about the methodology are provided in the Supporting Information.
Results
TARGET DISRUPTION OF THE CD36 GENE PROTECTS MICE FROM ConA-INDUCED LIVER INJURY
To investigate the role of CD36 in experimental T cell-mediated hepatitis, we injected ConA intravenously into male WT mice and CD36 2/2 mice. Eight hours later, blood was collected and the serum ALT levels were measured. The ALT levels were significantly lower in CD36
2/2 mice compared with WT mice (Fig. 1A ). Histological analysis of liver tissue sections revealed that CD36 2/2 mice were less sensitive to ConA-induced hepatic injury (Fig. 1B) . Liver sections of WT mice showed widespread tissue necrosis after ConA injection, whereas CD36
2/2 mice presented minor areas of necrosis characterized by standard morphologic criteria.
The results of the TUNEL assay suggest significant hepatocyte death in WT mice dosed with ConA; this effect was markedly attenuated in CD36 2/2 mice (Fig.  1C) . Together, these results suggest that CD36 deletion protects mice from ConA-induced liver injury.
DELETION OF CD36 REDUCES HEPATIC TNF-A EXPRESSION AND Jun N-TERMINAL KINASE ACTIVATION
T helper 1 cytokines, including IFN-c, IL-2, and TNF-a, are involved in ConA-induced liver injury. (13, 14) Therefore, we examined whether CD36 deficiency influences the expression of these cytokines in the liver. The TNF-a messenger RNA (mRNA) levels were significantly lower in CD36 2/2 mice than in WT mice at 8 hours after ConA injection ( Fig. 2A) . However, there was no significant difference in the levels of hepatic IFN-c mRNA.
TNF-a is capable of inducing the activation of caspase 3 via the TNF receptor, resulting in hepatocyte apoptosis. The expression level of cleaved caspase-3 was markedly higher in WT mice than in CD36 2/2 mice after ConA injection (Fig. 2B ). Jun N-terminal kinase (JNK) is a contextual modulator of TNFinduced apoptosis.
(15) Jnk1 2/2 and Jnk2 2/2 mice are protected from ConA-induced liver injury. (16) Moreover, in a previous study, hematopoietic deficiency in JNK1 and JNK2 prevented ConA-induced hepatitis, suppressing TNF production. (17) Accordingly, in the current study, phosphorylation of JNK p54 was increased by ConA administration in the livers of WT but not CD36 2/2 mice (Fig. 2B ).
CD36 DEFICIENCY ATTENUATES THE HEPATIC INFLAMMATION RESPONSE
CD36 contributes to macrophage and adipose tissue inflammation. (18, 19) Therefore, we examined the expression of proinflammatory mediators in the livers of WT and CD36
2/2 mice. The IL-1a, IL-6, and MCP-1 mRNA levels were significantly lower in ConA-treated CD36 2/2 mice than in WT mice, whereas there was no significant difference in the mRNA levels of IL-1b, IL-4, and IL-10 between the WT and CD36 2/2 mice (Fig. 3A) . We also measured the murine serum levels of 2/2 mice were stained with TUNEL. **P < 0.01, ***P < 0.001 versus WT mice.
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proinflammatory mediators. IL-6 and MCP-1 levels were significantly lower in ConA-treated CD36
2/2 mice than in WT mice (Fig. 3B) . Previous studies have reported that the CD36 receptor physically associates with MEKK2 and three members (Fyn, Yes, and Lyn proteins) of the Src family of protein tyrosine kinases; this association initiates a proinflammatory signaling cascade involving Fyn and p44/42 mitogenactivated protein kinase. (20, 21) CD36 also functions as a TLR2-TLR6 coreceptor to stimulate sterile inflammation by activating nuclear factor kappa B (NF-jB) through the MyD88 and TRIF adaptors. (4) Moreover, signaling through TLR2, TLR3, TLR4, TLR6, and TLR9 contributes to liver injury in ConA-induced hepatitis. (22, 23) Therefore, we investigated the activation of the extracellular regulated protein kinase (ERK), signal transducer and activator of transcription 3 (STAT3), and NF-jB signal pathways. There was no difference in the phosphorylation status of ERK and STAT3 between WT and CD36 2/2 mice, whereas the phosphorylation level of inhibitor of NF-jB (IKK) a was obviously lower in CD36 2/2 mice than in WT mice after ConA administration (Fig. 3C ).
CD36 EXPRESSION ON NONHEMATOPOIETIC CELLS DRIVES ConA-INDUCED NECROTIC CELL DEATH IN THE LIVER
To investigate whether the CD36 receptor is related to ConA-induced influx of MNCs in the liver, we characterized the hepatic cell population by flow cytometry. Eight hours after ConA injection, the total number of liverinfiltrating MNCs, CD3
1 cells, CD4 1 cells, CD8 1 T cells, NK cells, and NKT cells was lower in CD36 2/2 mice than in WT mice (Fig. 4A) . In addition, the total number of hepatic-infiltrating macrophages (CD11b 1
2/2 mice than in WT mice (Fig. 4A) . To determine the activation of LMNCs, intracellular staining of TNF-a or IFN-c were performed and analyzed using flow cytometry. First, CD45-positive cells were gated to exclude hepatocytes and LSECs (CD45
2/2
). Similar to our previous findings, (10) (Fig. 4B) . The percentages of TNFa-positive KCs significantly increased in both WT and CD36 2/2 mice after ConA treatment. However, no significant differences were observed between them. There was no significant increase in the percentages of TNF-apositive Ly6C hi and Ly6C lo IMs between two types of mice after administration of ConA (Fig. 4B) . Interestingly, the number of liver NK cells increased, while the amount of hepatic NKT cells decreased after ConA treatment in both WT and CD36 2/2 mice. However, no significant differences were shown between the percentages of those cells from the two strains of mice (Fig. 4C) . Furthermore, no dramatic fold change differences in the percentages of TNF-a-or IFN-c-positive NK cells, NKT cells, CD4 mice upon ConA injection (Fig. 4C) . We further addressed the role of CD36 in hematopoietic cells in chimeric mice generated by adoptive transfer of WT or CD36 2/2 bone marrow into lethally irradiated WT recipient mice. Administration of ConA at 7 or 8 weeks after cell transplantation induced a similar degree of liver injury in both chimeric strains, as ALT and aspartate aminotransferase (AST) serum levels and liver necrotic areas were comparable in both groups (Fig. 4D) . These results suggest that the cell compartment responsible for the reduced liver inflammation and damage in CD36 2/2 mice is not hematopoietic. (B) Liver JNK, p-JNK, and cleaved caspase-3 protein levels were determined using western blotting. Data represent the mean 6 SEM of three independent experiments. *P < 0.05; **P < 0.01.
GENISTEIN ATTENUATES ConA-INDUCED LIVER INJURY IN C57BL/6J MICE
The kinase Lyn has been identified as a CD36 binding protein to facilitate TLR4-TLR6 heterodimerization and signal initiation.
(4) Therefore, we examined the activation of Lyn in murine livers, primary hepatocytes, and LMNCs. Significantly higher expression of p-Lyn was observed in the liver tissues and hepatocytes from WT mice after ConA treatment rather than LMNCs. However, the elevation was significantly reduced in CD36 2/2 mice (Fig. 5A) . Genistein was shown to block the CD36-TLR4-TLR6-dependent activation of NF-jB reporter gene expression.
(4) Therefore, we treated WT mice with genistein to further elucidate the role of CD36 in ConAinduced liver injury.
Administration of genistein significantly reduced serum ALT level after ConA-treatment (Fig. 5B) . This finding is consistent with the scarce necrotic areas observed in the livers of genistein-treated animals, in contrast to significantly larger necrotic areas in the liver parenchyma of mice treated with ConA only (Fig. 5C) .
Next, we examined whether genistein could influence the infiltration of MNCs into the livers of mice after ConA injection. In line with the results obtained for CD36 2/2 mice (Fig. 4) , we found a significantly lower percentage and total number of infiltrating MNCs, CD3 (Fig. 5D ).
CXCL10 INDUCES HEPATOCYTE APOPTOSIS THROUGH CD36 SIGNALING
CXCL10 expression is positively associated with the severity of hepatitis C virus-induced liver disease mediated through CXCR3, (24) and it has been implicated in non-chemokine receptor-mediated apoptotic effects in cell culture and a ConA model. 2/2 mice. Representative blots from three independent experiments are shown. *P < 0.05; **P< 0.01; ***P < 0.001.
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Therefore, the expression levels of three predominant ligands of CXCR3, including CXCL9, CXCL10, and CXCL11, were determined in the livers of ConAtreated WT and CD36 2/2 mice. The mRNA levels of all three ligands were significantly increased after ConA-treatment in WT mice, and the elevation in the CXCL10 mRNA level was the highest (Fig. 6A) . Moreover, there was no difference in CXCL9 mRNA level between ConA-treated WT and CD36 2/2 mice. In contrast, the CXCL10 and CXCL11 mRNA levels were significantly lower in ConA-treated CD36 2/2 mice than in WT mice, where the fold changes were approximately 22.9 and 2.6, respectively. Moreover, CXCL10 mRNA levels were significantly lower in the primary hepatocytes from ConA-treated CD36 2/2 mice than those in WT mice (Fig. 6B) .
To define other cellular sources of CXCL10 in LMNCs, intracellular staining of CXCL10 was performed and analyzed using flow cytometry. Interestingly, the percentage of CXCL10-positive Ly6C hi IMs rather than Ly6C lo IMs and KC significantly increased in both WT and CD36 2/2 mice after ConA treatment. The combined results of two independent experiments with eight animals per group are shown as the mean 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
However, no dramatic differences were observed between two types of mice (Fig. 6C) . In addition, administration of ConA led to a significant increase in the percentage of CXCL10-positive hepatic NK cells in WT mice rather than CD36 2/2 mice (Fig. 6D ).
CXCL10 neutralizing antibodies were further used to examine its proapoptotic role in ConA model. As a result, neutralization of CXCL10 ameliorated mouse liver injury as proved by ALT levels, p-JNK expression, and H&E staining (Fig. 7) . Next, we examined the effects of CXCL10 on primary hepatocytes from WT and CD36 2/2 mice in vitro. The AST levels in the supernatant were significantly increased in the culture of hepatocytes from WT mice in the presence of CXCL10, whereas there was no difference in that of hepatocytes from CD36 2/ 2 mice after CXCL10 challenge (Fig. 8A) . Furthermore, we examined the potential molecular mechanism of CXCL10 in hepatocyte apoptosis. As shown in Figure 8B , IKKa/b phosphorylation occurred at 5 minutes after CXCL10 addition in WT hepatocytes and was sustained during the whole 8-hour culture period. On the other hand, no IKKa/b activation was observed in CXCL10-treated CD36 2/2 hepatocytes. Additionally, Akt phosphorylation appeared at 5 minutes after CXCL10 addition in WT hepatocytes, and peaked at 1 hour. In contrast, the activation of Akt was much less in CXCL10-treated CD36 2/2 hepatocytes (Fig.  8B) . Moreover, higher p-JNK levels were seen at 1 hour and up to 8 hours in WT hepatocytes cultured in the presence of CXCL10, compared with the levels in CD36 2/2 hepatocytes (Fig. 8B) . Thus, the activation of CD36 signaling appears to be essential for triggering CXCL10-induced hepatocyte apoptosis.
GENISTEIN REDUCED THE CXCL10-INDUCED ACTIVATION OF Akt AND JNK IN HEPATOCYTES FROM WT C57BL/6J MICE
Genistein, which blocked CD36 signaling, also ameliorated ConA-induced mouse liver injury in vivo. Next, we investigated the protective mechanisms of genistein in CXCL10-induced primary hepatocyte apoptosis in vitro. CXCL10 was able to activate Akt at 20 minutes, 60 minutes, 4 hours, and 8 hours in primary WT hepatocytes, whereas the addition of genistein blocked its effect (Fig. 8C,D) . Similarly, genistein reduced the phosphorylation of JNK induced by CXCL10 at 60 minutes and 4 hours (Fig. 8C,D) .
Discussion
In this study, we demonstrate that CD36 deficiency leads to a marked attenuation of ConA-induced hepatitis accompanied by reduced LMNCs, including CD4 Massive hepatocyte necrosis was observed in ConA-treated WT mice injected simultaneously with PBS or rat IgG, whereas less severe liver damage was observed in the mice injected with CXCL10 antibody. **P < 0.01; ***P < 0.001. neutrophils, decreased protein levels of p-JNK, pIKKa/b, and cleaved caspase-3, and reduced expression of inflammatory mediators (TNF-a, CXCL10, IL-1a, MCP-1, and IL-6). The chemokine CXCL10 is functionally involved in hepatocyte apoptosis through TLR4, independent of its receptor CXCR3. (26) Our data reveal that the proapoptotic role of CXCL10 is also mediated by the CD36 receptor. Furthermore, we demonstrate that treatment of WT mice with genistein attenuated ConA-induced liver injury and reduced the number of MNCs.
As a scavenger receptor, CD36 plays an important role in inflammation, immunity, metabolism, angiogenesis, atherosclerosis, and phagocytosis. (3) Macrophages that lacked CD36 failed to elicit IL-1b production in response to specific NLRP3 ligands. (5) Moreover, CD36 contributes to inflammation and macrophage infiltration in adipose tissue after a highfat diet, and JNK activation is reduced in white adipose tissue from CD36-deficient mice. (27) In line with these observations, we found that CD36 2/2 mice exhibited a markedly reduced number of liver-infiltrating effector cells (Fig. 4) , supporting a key role of CD36 in driving liver inflammation. Significantly lower levels of TNF-a, IL-1a, MCP-1, and IL-6 were seen in ConA-treated CD36 2/2 mice were measured in primary WT hepatocytes at various time points by way of western blotting. Primary hepatocytes were stimulated with genistein (5 lM), CXCL10 (100 ng/mL), and the combination of genistein and CXCL10, respectively. CXCL10 activated hepatic Akt and JNK within 60 minutes (C), and the activation was sustained for at least 8 hours (D). The addition of genistein significantly attenuated the activation of Akt and JNK by CXCL10 at 1 and 4 hours (C and D). The representative blots shown are from three independent experiments. *P < 0.05, **P < 0.01; ***P < 0.001. compared with WT mice (Fig. 2A,B) . Proinflammatory cytokines such as TNF-a and IFN-c play a central role in the pathogenesis of ConA-induced hepatitis. (13, 14) Notably, the anti-TNF-a agent infliximab has been found to be effective in the treatment of autoimmune hepatitis patients not responding to other therapies. (28) ConA is able to stimulate the production of cell-bound TNF-a, which binds to the TNF receptor to induce JNK activation. (29) Under certain conditions, JNK activation in hematopoietic cells is required for the optimal production of TNF-a, which is essential for ConA-induced hepatitis. (30) In line with this finding, we observed reduced activation of JNK and levels of cleaved caspase-3 in the livers of ConAtreated CD36
2/2 mice compared with WT mice. Furthermore, TNF-a can activate IKK, (31) and therefore, the attenuated activation of IKKa/b observed in ConA-treated CD36 2/2 mice (Fig. 3C ) may result from the reduced TNF-a level (Fig. 3A) .
Although T lymphocytes are the major effector cells involved in ConA-mediated hepatitis, it has been found that ConA binds to sinusoidal endothelial cells and KCs first, resulting in the trafficking of lymphocytes into the liver parenchyma. (8, 9, 32) Additionally, KCs, infiltrating macrophages, and neutrophils contribute to the induction of acute liver inflammation in mouse models of hepatitis. (22, 33, 34) Accordingly, fewer infiltrating CD11b (Fig. 4A) , indicating a key role of CD36 in promoting hepatic inflammation. Interestingly, lethally irradiated WT mice receiving transplantation of bone marrow cells from either WT or CD36 2/2 mice show a similar degree of liver damage upon ConA treatment. These data suggest that CD36 expression on nonhematopoietic cells is required to drive ConA-induced liver injury.
Intrahepatic CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. (24) Our data reveal that the expression levels of CXCL10 and CXCL11, but not CXCL9, were significantly decreased in CD36 2/2 mice (Fig. 6A) . In particular, the fold change of CXLC10 expression was more dramatic. CXCL10 has proapoptotic effects, mediated by the TLR4 receptor, in hepatocytes. (26) Neutralization of CXCL10 ameliorated ConAinduced mouse liver injury (Fig. 7) . Our data further demonstrate that CD36 is essential for CXCL10-induced hepatocyte apoptosis as well as IKK, Akt, and JNK activation in vitro (Fig. 8A,B) . The kinase Lyn has been identified as a CD36 binding protein to facilitate TLR4-TLR6 heterodimerization and signal initiation. (4) Next, the activation of Lyn was examined in the livers and primary hepatocytes from ConA-treated WT and CD36 2/2 mice. As a result, the p-Lyn level was dramatically reduced in CD36 2/2 mice compared with WT mice (Fig. 5A) . Therefore, we administered the Lyn inhibitor genistein in a mouse model of hepatitis. Notably, genistein reduced liver injury and expression of proinflammatory mediators, as well as the numbers of CD4
1 cells, CD8 1 T cells, NK cells, infiltrating macrophages, and neutrophils (Fig.  5B,C,D) . Moreover, genistein reduced the activation of Akt and JNK in the primary hepatocytes induced by CXCL10 in vitro (Fig. 8) .
In conclusion, we propose that the scavenger receptor CD36 plays an important proinflammatory role in ConA-induced liver injury by promoting hepatic inflammation and mediating the proapoptotic effect of chemokine CXCL10. Our findings suggest a potential use of genistein as an anti-inflammatory and immunomodulatory drug to treat immune-mediated hepatitis. CD36 may therefore be a potential target for therapeutic intervention in acute liver failure.
